This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy Policy.

Leading in China丨BioGerm Monkeypox Viral Nucleic Acid Test Kit (PCR-Fluorescence Probing) Granted CE Approval!

Recently, an outstanding newcomer was incorporated into BioGerm CE certificated family - BioGerm Monkeypox Viral Nucleic Acid Test Kit (PCR-Fluorescence Probing) was granted EU CE certification, showing that the quality of BioGerm medical products is recognized and ratified by international authorities once again.

May 30,2022

The World Health Organization (WHO) stated on May 20 that it had recently received reports from several countries on about 80 monkeypox cases, and there were another 50 cases to be confirmed. WHO convened a meeting of experts and technical advisory group on May 20 to exchange global relevant information about monkeypox and the response to the virus. To date, monkeypox cases have been reported in several countries in succession, including Britain, Spain, Portugal, Germany, Italy, the United States, Canada and Australia.    


BioGerm Monkeypox Viral Nucleic Acid Test Kit (PCR-Fluorescence Probing) was Granted CE Approval on May 23, 2022.


BioGerm Monkeypox Viral Nucleic Acid Test Kit (PCR-Fluorescence Probing) CE Certification

Benefiting from its world-leading diagnostic technology platform, BioGerm responded swiftly to the monkeypox virus outbreak and launched the Monkeypox Viral Nucleic Acid Test Kit (PCR-Fluorescence Probing). At present, the performance validation of the product has been completed in Sierra Leone with excellent experimental results. The product is able to identify monkeypox virus swiftly via specifically detecting the nucleic acid fragment of monkeypox virus. The reagent features high sensitivity and easy operation. It is suitable for the rapid diagnosis of diseases related to monkeypox virus infection, and is compatible with the fluorescent PCR platform, which can be quickly applied on the established 2019-nCoV nucleic acid test platform.


BioGerm has been holding fast to the innovation-driven and quality-first philosophy all along. Dedicated to research and development, BioGerm is committed to becoming a world-leading pathogen diagnostic expert to “save one hour for patients” by providing state of the art products and services. To date, BioGerm's products have been serving tens of thousands of laboratories at home and abroad, which can aid laboratories worldwide to conduct monkeypox viral nucleic acid test effectively, and facilitate the rapid diagnosis, prevention and control of monkeypox.